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OBJECTIVE — Todeterminetheprevalenceofmacroalbuminuriaandtodescribetheclinical
and renal pathological changes associated with macroalbuminuria in a population of Canadian
First Nation children and adolescents with type 2 diabetes.
RESEARCH DESIGN AND METHODS — We conducted a retrospective chart review
at a single tertiary care pediatric diabetes center, and a case series was constructed. We collected
data on microalbuminuria (3 mg/mmol creatinine [26.5 mg/g]) and macroalbuminuria (28
mg/mmol creatinine [247.5 mg/g]), estimated glomerular ﬁltration rate, renal pathology, and
aggravating risk factors (poor glycemic control, obesity, hypertension, glomerular hyperﬁltra-
tion, hypercholesterolemia, smoking, and exposure to diabetes in utero).
RESULTS — We reviewed 90 charts of children and adolescents with type 2 diabetes. A total
of 53% had at least one random urine albumin-to-creatinine ratio 3 mg/mmol (26.5 mg/g).
There were 14 of 90 (16%) who had persistent macroalbuminuria at or within 8 years of
diagnosisofdiabetes.Ofthese14subjects,1hadorthostaticalbuminuriaand3hadspontaneous
resolution of albuminuria. A total of 10 had renal biopsies performed. There were 9 of 10 who
exhibited immune complex disease or glomerulosclerosis, and none had classic diabetic ne-
phropathy.
CONCLUSIONS — This study suggests that the diagnosis of renal disease in children with
type 2 diabetes cannot be reliably determined by clinical and laboratory ﬁndings alone. Renal
biopsy is necessary for accurate diagnosis of renal disease in children and adolescents with type
2 diabetes and macroalbuminuria. The additional burden of nondiabetic kidney disease may
explain the high rate of progression to end-stage kidney failure in this population.
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T
he increasing prevalence of type 2
diabetes in children and youth has
beenwellrecognizedoverthepast2
decades. The geographic area in central
Canada including Manitoba and north-
western Ontario has the highest reported
prevalence of type 2 diabetes in youth in
Canada.Theprevalenceis1%inFirstNa-
tion children age 4–19 years in speciﬁc
communities from this region (1). A total
of 95% of the youth with type 2 diabetes
from this region have Canadian First Na-
tion heritage.
Hepatic nuclear factor (HNF)-1 is a
transcription factor expressed in many
tissues including the liver, intestine, pan-
creatic -cell, and kidney. A private poly-
morphism of this gene (HNF-1 G319S)
is found in the Oji-Cree of Manitoba and
northwestern Ontario. It has been associ-
atedwithearly-onsetdiabetesinthispop-
ulation and demonstrates a genotype-
phenotype relationship (2,3).
Youth-onset type 2 diabetes is associ-
ated with an increased incidence of end-
stage kidney disease (ESKD) and
mortality in middle-age in the Pima Indi-
ans of the southwestern U.S. (4). ESKD
has been reported before the age of 30
years in Canadian First Nation young
adultswhohadtype2diabetesdiagnosed
inadolescence(5).Inthisseries,thecause
of ESKD was attributed to diabetic ne-
phropathy, since proteinuria was de-
tected after the onset of diabetes. Renal
biopsy was not performed to conﬁrm the
diagnosis and/or exclude other causes of
kidney disease. Several small studies have
reported an increased frequency (27–
40%) of microalbuminuria in youth with
type2diabetes(6,7).Thesestudiesassessed
microalbuminuria at a single time point
and did not describe evolution over time.
Primary nondiabetic renal disease is
frequent in the First Nation population.
Canadian First Nation children without
diabetes have an increased rate of both
congenital and acquired primary renal
disease (8). First Nation adults also have
an increased risk ratio for nondiabetic
ESKD (9). In both First Nation children
and First Nation adults, the most com-
mon renal pathology is primary glomeru-
lonephritis. Childhood obesity is also
increasingly common in this population
and independently predisposes to sec-
ondaryfocalglomerulosclerosisandrenal
failure in children and adults (10,11).
Diabetes-associated ESKD is seven
times more frequent in First Nation com-
pared with non–First Nation people in
Canada (12). There is also a twofold in-
crease in premature mortality rate in First
Nation adults with diabetes compared
with individuals with diabetes from the
general Canadian population (12). It is
thus imperative to describe and under-
stand the natural history and etiology of
renal disease in First Nation youth with
type 2 diabetes as the ﬁrst step in the de-
velopment of intervention and treatment
strategies in this vulnerable population.
The frequency of macroalbuminuria
has not previously been described in the
pediatricpopulationwithtype2diabetes,
nor has the nature of the associated renal
pathology. The objectives of this study
were to determine the prevalence of mac-
roalbuminuria and to characterize the
clinicalandrenalpathologicalchangesas-
sociatedwithmacroalbuminuriainapop-
ulation of First Nation children and
adolescents with type 2 diabetes.
RESEARCH DESIGN AND
METHODS— Clinic charts of chil-
drenandadolescentswithtype2diabetes
followed at the Diabetes Education Re-
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(DER-CA) at the Winnipeg Children’s
Hospital, MB, Canada, were reviewed be-
tween September and October 2003, and
a case series of patients with macroalbu-
minuria was constructed. Case subjects
were identiﬁed through the clinical data-
base maintained at the DER-CA. The
DER-CA is associated with the only ter-
tiary care pediatric hospital in the province
of Manitoba, Canada, with a catchment
population of 1.2 million people.
Height, weight, blood pressure, self-
declared ethnicity, sex, age, self-reported
smoking status, history of prenatal expo-
sure to hyperglycemia, and laboratory
data (A1C, albumin, creatinine, urine al-
bumin-to-creatinine ratio [ACR] and/or
timedurinarycollectionsforalbuminand
protein, and HNF-1 G319S genotype)
were extracted from the chart. BMI was
calculated and presented as BMI z score.
Obesity was deﬁned as 95th percentile
for age and sex (13). Blood pressure per-
centiles were deﬁned using the National
Heart, Lung, and Blood Institute blood
pressure levels for age, sex, and height
percentile (14), and fasting cholesterol
level was deﬁned according to the Na-
tional Cholesterol Education Program
data (acceptable 4.4 mmol/l). Glomer-
ularﬁltrationratewasestimatedusingthe
Schwartz formula and expressed as ml/
min per 1.73 m
2.
The diagnosis of diabetes was made
according to the criteria of the American
Diabetes Association (15). The diagnosis
of type 2 diabetes was based on clinical
criteria including presence of obesity, ac-
anthosis nigricans, family history of type
2 diabetes, and family heritage from a
high-risk ethnic group (16). When avail-
able, the absence of diabetes-associated
autoantibodies was used to support the
diagnosis of type 2 diabetes (17).
Microalbuminuria was deﬁned as
urine ACR 3–28 mg/mmol (26.5–247.5
mg/g) or quantitatively as 30–300 mg al-
bumin/24 h. Macroalbuminuria was de-
ﬁnedasurineACR28mg/mmol(247.5
mg/g) or quantitatively as 300 mg albu-
min/24 h. Persistent micro- or mac-
roalbuminuriawasdeﬁnedastwoofthree
positive samples over 6 months. These
patients underwent split timed-urine col-
lections and/or a minimum of three ﬁrst-
morning urine collections to identify
subjects with orthostatic proteinuria. The
standard approach to treatment of albu-
minuria in our clinic is the use of an ACE
inhibitorandinvestigationsaimedatcon-
ﬁrmation of etiology.
Renalbiopsywasperformedinpatients
with persistent nonorthostatic macro-
albuminuria (28 mg/mmol [247.5 mg/
g]). Standard renal histology techniques
included light microscopy (hematoxylin
and eosin, periodic acid-Schiff, periodic
acid methenamine silver, trichrome, sirius
red), immunoﬂuorescence studies (IgG,
IgA,IgM,C1q,C3,properdin,ﬁbrinogen,
,and),andelectronmicroscopy.Renal
biopsysampleswereconsideredadequate
if they contained a minimum of two cores
with a minimum of 10 glomeruli. All bi-
opsieswereinterpretedbyasinglepathol-
ogist (I.W.G.) who is a specialist renal
pathologist. For those undergoing renal
biopsy, clinical and biochemical ﬁndings
are reported at the time of biopsy or the
most proximal clinic visit.
A1C was measured using the DCA
2000 immunoassay (normal range
4–6%, Bayer Diagnostics). Fasting total
cholesterol was measured before April
2003 using the Hitachi 917 Clinical
Chemistry Autoanalyzer (Roche) and on
the Roche Modular Analytics Analyzer af-
ter 2003. Plasma and urine creatinine
weremeasuredbykineticcolorimetricas-
sayusingtheJaffemethod.Urinealbumin
was measured by immunoturbidimetric
assay using an anti-excess reagent. Geno-
typing for the HNF-1 G319S polymor-
phism was performed by the Molecular
GeneticLaboratory(HealthSciencesCen-
tre, Winnipeg, MB, Canada).
RESULTS— All clinical records of
children and adolescents with type 2 dia-
betes followed at the DER-CA during the
study period were reviewed. All patients
had random urine ACR done at diagnosis
and annually unless abnormal. If ele-
vated, a ﬁrst-morning ACR was per-
formed at each clinical visit (typically
every 4 months). Of the 90 records re-
viewed, 88 (98%) were of self-declared
First Nation or Me ´tis heritage. The male-
to-femaleratiowas1:1.2.Themeanageof
this population was 15.2 years with a
range from 10 to 19 years. Mean duration
of diabetes was 2.5 years (range 0.4–5).
Mean BMI z score at diagnosis was 1.88
(range 1.17 to 2.95). Approximately
80% lived outside urban centers in rural
or remote settings.
Of the 90 children and adolescents,
48 (53%) had at least one ACR 3 mg/
mmol (26.5 mg/g). A total of 26 of 90
(29%) had an elevated ACR at diagnosis
of diabetes. A total of 14 of 90 (16%) had
persistent macroalbuminuria. All youth
with persistent macroalbuminuria were
of self-declared First Nation descent.
Ofthe14withpersistentmacroalbu-
minuria, 1 was shown with further test-
ing to have orthostatic albuminuria, 3
hadresolutionofthealbuminuriaovera
6-month period awaiting workup and
continuedtobemonitoredclosely,and10
had a renal biopsy (3 female and 7 male).
Of those biopsied, the mean age at
diagnosis of diabetes was 12 years (range
9.7–16.7).Thedurationofdiabetesatthe
time of biopsy ranged from 4 months to 8
years. Four of these 10 youth had mac-
roalbuminuria at diagnosis. A total of 7 of
10wereonanACEinhibitoratthetimeof
biopsy (case subjects 1, 2, 3, 4, 5, 9, and
10). The remaining three were started on
an ACE inhibitor after biopsy (case sub-
jects6,7,and8).Thesethreehadallbeen
diagnosedwithdiabetesfor12months.
The mean A1C in the year preceding bi-
opsyrangedfrom5.3to12.5%.In6of10
individuals, systolic blood pressure was
above the 95% percentile for age and sex.
Fasting total cholesterol was elevated in
all 10 (Table 1). A total of 4 of 10 were
self-reported smokers (2 girls, 2 boys),
and 6 of 10 were exposed in utero to dia-
betes, either from conception (prepreg-
nancy type 2 diabetes) or during
pregnancy (gestational). The HNF-1
G319S polymorphism haplotype was
present in 4 of 7 patients in whom geno-
typing was available (Table 1). Seven of
10 were obese with unbalanced distribu-
tion among individuals with the HNF-1
G319S polymorphism haplotype present
(meanBMIzscore1.4)andthosewithout
(mean BMI z score 2.6).
Biopsy results indicate signiﬁcant
nondiabetic renal pathology (Table 2).
Twoorthreecoreswereobtainedforeach
patient with 12–25 total glomeruli per
sample. Histological changes typically as-
sociated with diabetes were infrequently
noted and were insufﬁcient to make a de-
ﬁnitive diagnosis of diabetic nephropathy
in any of the cases. Diabetes-related le-
sionsseenincludedfocal,mildhyalinear-
teriolosclerosis (case subject 10), focal
and mild glomerular basement mem-
branethickening(casesubjects6and10),
and a single Bowman’s capsular drop
(case subject 6).
Half of the patients exhibited evi-
dence of immune complex deposition
thatwaseitherIgA(n3)or“full-house”
immune complex deposition (n  2). In
the latter group, a diagnosis of systemic
lupus was eventually conﬁrmed in both.
One of these (case subject 1) had World
Sellers and Associates
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pus with membranous nephropathy
changes; the other (case subject 5) had
WHOclassIIBmesangiallupusnephritis.
In those with IgA deposition, there was
minimal-to-mild mesangial proliferation
despite signiﬁcant albuminuria.
A total of 90% of biopsies had at least
one glomerulus exhibiting segmental or
global glomerulosclerosis, and 60% had
more than one glomerulus involved. In
70%, there was focal segmental glomerulo-
sclerosis,withthreecasesshowingperihilar
lesions,onecaseshowingglomerulartiple-
sion, and three cases showing peripheral
segmental lesions. In 80%, the glomeruli
were diffusely enlarged (case subjects 1, 2,
3, 4, 5, 7, 8, and 9).
Complete and accurate timed urine
collections to calculate creatinine clear-
ance are difﬁcult to obtain reliably, and
thus the Schwartz estimate was used. To
validate this approach, a subcohort anal-
ysiswasdoneusingallavailableurinecol-
lections for the patients reported in this
study (n  90). Only nine urine collec-
tions were suitable and complete (a min-
imum of 8 mmol/day [0.13 mmol   kg
1  
day
1] of creatinine excretion). The uri-
nary creatinine clearance was calculated
and correlated with the Schwartz esti-
mated glomerular ﬁltration rate (eGFR),
usingk0.7forboys12yearsold,and
k  0.55 for the remainder. Schwartz
eGFRshowedgoodcorrelation(r0.67,
P  0.046) and overestimated GFR in
pair-wise comparison by 12 	 15% (data
not shown). The mean body surface area
in this subcohort was 2.1 	 0.4, so as a
conservative measure, the eGFR cor-
rectedto1.73m
2ratherthantheabsolute
clearance was reported.
For the patients reported in this se-
ries, all but one patient (subject 9) had
elevated eGFR suggesting hyperﬁltration,
Table 1—Patient characteristics
Sex
Age at diagnosis
(years)
Age at biopsy
(years)
BMI z
score
Systolic blood
pressure 95th
percentile
Mean
A1C (%)*
Fasting total
cholesterol
(mmol/l)
Maternal diabetes
during pregnancy
HNF-1 G319S
polymorphism
1 F 10.0 17.8 1.0 No 10.1 5.09 No Homozygote
2 M 12.3 12.9 2.9 Yes 6.3 5.02 Pre-pregnancy NA
3 M 11.1 15.1 1.8 Yes 11.2 8.26 No Heterozygote
4 M 13.9 17.4 2.1 No 8.5 4.41 No Wild-type
5 F 13.3 15.6 2.6 No 6.0 6.00 No NA
6 M 10.3 10.7 1.1 No 8.5 5.26 Gestational Heterozygote
7 M 16.7 17.1 2.8 Yes 6.0 4.71 Gestational NA
8 M 11.3 12.5 2.7 Yes 12.5 5.94 Pre-pregnancy Wild type
9 M 12.3 13.5 2.5 Yes 5.3 5.00 Gestational Wild type
10 F 9.7 17.7 1.6 Yes 11.0 6.44 Gestational Heterozygote
*Mean A1C in 12 months before biopsy. NA, not available.
Table 2—Hyperﬁltration, albuminuria, and histological ﬁndings
eGFR‡
Urine ACR
(mg/mmol)
Focal segmental
glomerulosclerosis
Global
glomerulosclerosis
Mesangial
proliferation Immunoﬂuorescence Other pathological ﬁndings
1 156 270* — — Mild Mesangial and capillary
loop IgG, IgA, IgM,
C3, C1q
Subepithelial and mesangial
deposits, epimembranous
spikes
2 204 66 2/12 perihilar 1/12 Mild Mesangial IgA Focal mild chronic
tubulointerstitial damage
3 162 105 — 1/25 — Negative —
4 144 61 3/9 perihilar 1/9 — Negative Mild-moderate chronic
tubulointerstitial damage
5 415 17† 2/19 — Mild Mesangial and capillary
loop IgG, IgA, IgM,
C3, C1q
Paramesangial deposits and
mesangial sclerosis
6 194 178 1/22 1/22 — Negative Mild GBM thickening,
capsular drop
7 215 117 1/22 1/22 — Negative —
8 190 215 1/14 tip lesion — Minimal Mesangial IgA Focal arteriolosclerosis
9 118 290 5/13 perihilar 1/13 — Negative Mild-moderate chronic
tubulointerstitial damage
10 210 23† — 1/18 Segmental mild Mesangial IgA Focal arteriolosclerosis,
mild GBM thickening
*Estimated based on proteinuria of 3.6 g/day. †Persistent macroalbuminuria documented in these patients; ACR most proximal to time of biopsy demonstrated
microalbuminuria. ‡eGFR (ml/min per 1.73 m
2) estimated by calculation of size-adjusted creatinine clearance using the Schwatrz formula. When ACR 200
mg/mmol, the urine total protein-to-creatinine ratio is reported. GBM, glomerular basement membrane.
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cess of 200 ml/min per 1.73 m
2. The pa-
tient with “normal” eGFR (subject 9) and
38% segmental glomerulosclerosis at the
time of biopsy had demonstrable hyper-
ﬁltration at initial diagnosis (eGFR  217
ml/minper1.73m
2)andhascontinuedto
have declining glomerular ﬁltration rate
in follow-up (at age 16 years, eGFR  44
ml/min per 1.73 m
2).
Threecasesexhibitednephroticrange
proteinuria (ACR 200 mg/mmol [1,768
mg/g]), including one patient whose bi-
opsy showed membranous nephropathy
changes. Two of these three (subjects 1
and 9) had hypoalbuminemia (serum al-
bumin: 27 and 32 mg/l, respectively).
Twocases(5and10)withpersistentmac-
roalbuminuria before biopsy had ACR
28mg/mmol(247.5mg/g)atthetime
ofbiopsy.Inthesecases,concomitantim-
mune complex deposition was noted in
association with mild mesangial prolifer-
ation. The remaining cases had glomeru-
losclerosis and/or immune complex
diseaseofsufﬁcientseveritytoaccountfor
the presence of macroalbuminuria.
CONCLUSIONS — Persistent mac-
roalbuminuria was documented in 16%
of this population of children and adoles-
cents with type 2 diabetes at, or within 8
years of, diagnosis. The biopsy results
demonstrate that nondiabetic renal dis-
ease in the form of immune complex dis-
ease or glomerulosclerosis is the most
commonetiologyofmacroalbuminuriain
this young population.
In adults with type 2 diabetes, renal
biopsy frequently identiﬁes nondiabetic
pathology. In a multicenter study of
adults with type 2 diabetes undergoing
renal biopsy, 45% (177/393) were diag-
nosed with nondiabetic glomerular dis-
ease, either superimposed on diabetic
nephropathy (17% of all biopsies) or
more commonly without underlying dia-
betic disease (28%) (18). The most com-
mon disease superimposed on diabetic
nephropathy was postinfectious glomer-
ulonephritis, and the most common glo-
merular diseases without underlying
diabetic changes were membranous glo-
merulonephritis, IgA nephropathy, and
minimal change disease or focal segmen-
tal glomerulosclerosis. This is the ﬁrst re-
porttoourknowledgeofasimilarﬁnding
in the pediatric population. Our study
conﬁrms that renal pathology in children
with type 2 diabetes cannot be reliably
predicted by clinical and laboratory ﬁnd-
ings alone and that renal biopsy is neces-
saryforaccuratediagnosisofrenaldisease
in such patients.
HNF-1 is involved in the differenti-
ation of the nephron (19). Other domi-
nant mutations of the HNF-1 gene are
characterizedbyreducedrenaltubularre-
absorption of glucose (20). While the ef-
fectoftheprivateOji-Creepolymorphism
of the HNF-1 gene on the development
and function of the kidney is not known,
the observation that the polymorphism is
presentin4of7inwhomgenotypingwas
available is intriguing. We speculate that
this polymorphism may play a role in the
development of the renal pathology
found in this population.
Obesity is a well-recognized risk fac-
tor for insulin resistance and the develop-
ment of type 2 diabetes. Obesity is
associated with glomerular hyperﬁltra-
tion and the development of glomerulo-
sclerosis and kidney failure independent
of the presence of diabetes (10,11). The
biologic mechanisms explaining this as-
sociation are not fully understood but ap-
pear to be mediated through both
hemodynamic and hormonal effects.
Thoseincludeincreasedrenalbloodﬂow,
GFR, glomerular ﬁltration pressure and
ﬁltration fraction, hyperinsulinemia, and
activationoftherenin-angiotensinsystem
(11).
Furthermore, medications such as
ACE inhibitors, which may mitigate hy-
perﬁltration injury, are beneﬁcial in this
context (11,21). In our series, all of the
patients without the HNF-1 G319S
polymorphism had a BMI z score 2. Al-
though 8 of 10 patients had a body sur-
face area 1.73 m
2 (mean 2.1 m
2), the
eGFR corrected to 1.73 m
2 was reported
instead of the absolute GFR. By this con-
servative estimate, all patients currently
or previously had an eGFR 140 ml/min
per 1.73 m
2 and 4 of 10 had eGFR 200
ml/min per 1.73 m
2, which is higher than
is reported in adults with recent-onset
type 2 diabetes (22). In those with obe-
sity, this was associated histologically
with glomerulomegaly and signiﬁcant
glomerulosclerosis. The contribution of
obesity, diabetes, or the combination of
the two to the hyperﬁltration seen cannot
be differentiated. However, the presence
of obesity and hyperﬁltration likely con-
tributes to the evolution of renal injury in
this population and is likely additive to
the other effects that are typically associ-
ated with hyperglycemia.
In humans, nephrogenesis occurs be-
tween the 5 and 36 weeks of gestation,
and new nephron formation ceases after
36 weeks of gestation (23). In the rat
model,exposuretohyperglycemiaduring
gestation decreases nephron number in
the offspring by 35%. Minor elevations in
glucose are associated with abnormal
metanephros development in the off-
spring of streptozotocin-treated diabetic
rats (24). A decrease in nephron number
maypredisposetorenalpathologyinlater
life due to a reduction in renal reserve.
Both glomerulomegaly and glomerulo-
sclerosis are associated with decreased
nephron number, likely resulting from
the decreased ﬁltration surface and sub-
sequent glomerular damage resulting
from hyperﬁltration. In young adult Pima
Indians with type 2 diabetes, exposure to
diabetes in utero increases the odds of
having an elevated ACR by almost four-
fold (25). A total of 60% of the youth in
our series were exposed to either gesta-
tional or pregestational type 2 diabetes.
We postulate that this may have resulted
inadecreasednephronmass,accelerating
their presentation with macroalbumin-
uria. As rates of youth-onset type 2 diabe-
tes increase, the frequency of fetal
exposure to a diabetic environment will
also increase. This may have signiﬁcant
detrimental effects on the renal health of
subsequent generations.
Multiple risk factors for aggravating
renal disease were found in this cohort,
including obesity, glomerular hyperﬁltra-
tion, hypertension, hyperlipidemia,
smoking,poorglycemiccontrol,andfetal
exposure to a diabetic environment. This
multiplicity of risk factors may explain
the progression to ESRD at a relatively
young age that has been observed in this
population (5). Aggressive treatment of
modiﬁable risk factors is warranted to
prevent progression of renal disease and
topreventearlycardiovasculardiseaseas-
sociatedwithbothrenaldiseaseandthese
aggravating risk factors.
Limitations to this report include the
inability to obtain adequate, timed urine
samples in all patients. Despite attempts,
this testing presents signiﬁcant practical
challenges, particularly in adolescents
and in remote communities. In addition,
theﬁndingsofthisreportmaynotbegen-
eralizable to other pediatric populations
affected by type 2 diabetes.
Our study suggests that the diagnosis
of renal disease in children with type 2
diabetescannotbereliablydeterminedby
clinicalandlaboratoryﬁndingsalone.Re-
nal biopsy is necessary for accurate diag-
nosis in this population. This ﬁnding
needs conﬁrmation in other populations
Sellers and Associates
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dence of type 2 diabetes in First Nation
youth is increasing at an alarming rate.
The additional burden of nondiabetic
kidneydiseasemaycontributetothehigh
rate of progression to end-stage kidney
failure in this population.
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